<sup>18</sup>F-Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma as a Useful Predictor of an Extremely Rapid Response to Lenvatinib-Reference-Cited by-同舟云学术

¹⁸F-Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma as a Useful Predictor of an Extremely Rapid Response to Lenvatinib

Published:2019-11-13 Issue:1 Volume:9 Page:84-92
ISSN:2235-1795
Container-title:Liver Cancer
language:en
Short-container-title:Liver Cancer

Author:

Kawamura Yusuke,Kobayashi Masahiro,Shindoh Junichi,Kobayashi Yuta,Kasuya Kayoko,Sano Tomoya,Fujiyama Shunichiro,Hosaka Tetsuya,Saitoh Satoshi,Sezaki Hitomi,Akuta Norio^ORCID,Suzuki Fumitaka,Suzuki Yoshiyuki,Ikeda Kenji,Arase Yasuji,Hashimoto Masaji,Kumada Hiromitsu

Publisher

S. Karger AG

Subject

Oncology,Hepatology

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Giant Hepatocellular Carcinoma Successfully Treated with Lenvatinib Followed by Parenchymal-Sparing Hepatectomy;The Japanese Journal of Gastroenterological Surgery;2023-10-01

2. Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular Carcinoma;Cancers;2023-07-26

3. The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy;Frontiers in Immunology;2023-05-05

4. Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study;Clinical Cancer Research;2023-02-14

5. Complete Metabolic Response by 18F-FDG PET/CT to Atezolizumab Plus Bevacizumab in Patients With Advanced Hepatocellular Carcinoma;Clinical Nuclear Medicine;2023-01-20